US medical devices firm BioTek mulls $1bn sale

Bloomberg

BioTek Instruments Inc., a closely held US medical device maker, is exploring options including a sale amid interest from rivals and investment firms, according to people familiar with the matter.
BioTek could be valued at about $1 billion in a sale, said the people, asking not to be identified because the matter is private. Health care companies and investment funds have expressed preliminary interest in acquiring the whole company or a stake, the people said. The Winooski, Vermont-based company’s deliberations are continuing and a final decision on whether to pursue a deal hasn’t been made, the people said.
“BioTek is a privately held, family owned company,” Julie Bond, senior marketing operations manager with BioTek, said. “We frequently do receive inquiries from potential buyers but it’s our policy not to comment on any market rumors.”
BioTek makes cell-imaging systems, test-tube plate readers, incubators and other instruments and software for life sciences research and drug discovery, according to its website.